InsiderClue
← All stocks

Vera Therapeutics, Inc.

VERA Net buying
CIK 0001831828 #1966 in the set updated 17 Sep 2026
Bought (120 mo)
$115.15M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$84.99M
$6.45M on a plan · $22.72M straight out of an exercise
Sold at will
$55.83M
23 of 183 sales
Net
+$30.16M
+$59.33M against sales at will

By person

22 insiders · 238 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ENRIGHT PATRICK G
Director
$32.53M (8)
—
+$32.53M
6,699,069
9.30%
$235.24M
+415.7%
Longitude Capital Partners IV, LLC entity
10% owner
$27.00M (3)
—
+$27.00M
4,810,879
6.68%
$168.94M
—
Katabi Maha
Director
$13.00M (2)
$34.10M (6)
−$21.10M
5,708,763
7.92%
$200.47M
+64.7%
Fordyce Marshall
PRESIDENT AND CEO
—
$19.72M (84) scheduled
−$19.72M
235,244
0.3264%
$8.26M
+5,703%
Sofinnova Venture Partners X, L.P. entity
10% owner
$14.00M (3)
—
+$14.00M
3,467,156
4.81%
$121.75M
—
COMMODORE CAPITAL LP entity
10% owner
$6.80M (1)
$18.90M (1)
−$12.10M
4,400,000
6.11%
$154.51M
−12.0%
EMSTER KURT VON
Director
$8.71M (2)
—
+$8.71M
2,978,059
4.13%
$104.58M
—
Abingworth LLP
10% owner
$8.50M (1)
—
+$8.50M
2,960,231
4.11%
$103.95M
—
Grant Sean
CHIEF FINANCIAL OFFICER
$251.00K (6)
$4.90M (20) scheduled
−$4.65M
119,181
0.1654%
$4.19M
+1,548%
SEIDENBERG BETH C
Director
$4.32M (19)
$1.42M (5) scheduled
+$2.90M
1,478,717
2.05%
$51.93M
—
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
$40.00K (1)
$2.10M (7) scheduled
−$2.06M
80,754
0.1121%
$2.84M
+882.3%
Curley Joanne
Chief Development Officer
—
$1.82M (48) scheduled
−$1.82M
26,962
0.0374%
$946.79K
+0.5%
Turner William D.
Chief Regulatory Officer
—
$1.45M (4) scheduled
−$1.45M
45,313
0.0629%
$1.59M
—
Carlyle Group Inc. entity
10% owner
—
$201.03K (3) scheduled
−$201.03K
2,960,231
4.11%
$103.95M
0.0%
JOHNSON DAVID LEE
Chief Operating Officer
—
$108.28K (1)
−$108.28K
45,727
0.0635%
$1.61M
+3,152%
Carter Jason S
Chief Legal Officer
—
$107.50K (1)
−$107.50K
49,136
0.0682%
$1.73M
—
Brenner Robert
Chief Medical Officer
—
$90.31K (1)
−$90.31K
50,947
0.0707%
$1.79M
+4,153%
Skelton Laurence Matthew
Chief Commercial Officer
—
$66.42K (1)
−$66.42K
64,218
0.0891%
$2.26M
+40.2%
Lin Celia
Chief Medical Officer
—
$24.82K (1) scheduled
−$24.82K
11,010
0.0153%
$386.62K
—
Boman Nancy Lee
Chief Regulatory Officer
—
—
—
44,987
0.0624%
$1.58M
—
Wright-Mitchell Jane
Chief Legal Officer
—
—
—
42,403
0.0588%
$1.49M
—
Cheng Andrew
Director
—
—
—
17,488
0.0243%
$614.11K
—

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
ENRIGHT PATRICK G
11 Dec 2025
Director
Buy
5,882
$42.50
$249.99K
ENRIGHT PATRICK G
24 Jun 2025
Director
Buy indirect
27,071
$22.35
$605.08K
ENRIGHT PATRICK G
24 Jun 2025
Director
Buy indirect
13,536
$22.35
$302.55K
ENRIGHT PATRICK G
23 Jun 2025
Director
Buy indirect
139,595
$20.87
$2.91M
ENRIGHT PATRICK G
23 Jun 2025
Director
Buy indirect
69,798
$20.87
$1.46M
Katabi Maha
30 Jan 2024
Director
Buy indirect
161,290
$31.00
$5.00M
Grant Sean
23 Jun 2023
Chief Financial Officer
Buy indirect
5,000
$16.60
$83.00K
COMMODORE CAPITAL LP
20 Jun 2023
10% owner
Buy indirect
448,217
$15.17
$6.80M
SEIDENBERG BETH C
30 Mar 2023
Director
Buy indirect
2,300
$7.24
$16.65K
SEIDENBERG BETH C
28 Mar 2023
Director
Buy indirect
23,908
$7.24
$173.19K
SEIDENBERG BETH C
27 Mar 2023
Director
Buy indirect
1,633
$7.24
$11.83K
SEIDENBERG BETH C
24 Mar 2023
Director
Buy indirect
1,833
$7.24
$13.27K
SEIDENBERG BETH C
20 Mar 2023
Director
Buy indirect
15,252
$7.21
$110.03K
SEIDENBERG BETH C
17 Mar 2023
Director
Buy indirect
74,045
$7.12
$526.88K
SEIDENBERG BETH C
16 Mar 2023
Director
Buy indirect
60,097
$7.09
$426.27K
SEIDENBERG BETH C
15 Mar 2023
Director
Buy indirect
32,844
$7.12
$234.01K
SEIDENBERG BETH C
10 Mar 2023
Director
Buy indirect
48,003
$7.16
$343.49K
SEIDENBERG BETH C
3 Mar 2023
Director
Buy indirect
1,000
$7.25
$7.25K
SEIDENBERG BETH C
2 Mar 2023
Director
Buy indirect
23,378
$7.24
$169.32K
SEIDENBERG BETH C
1 Mar 2023
Director
Buy indirect
100
$7.25
$725.00
SEIDENBERG BETH C
23 Feb 2023
Director
Buy indirect
200
$7.24
$1.45K
SEIDENBERG BETH C
13 Feb 2023
Director
Buy indirect
10,072
$7.20
$72.49K
SEIDENBERG BETH C
9 Feb 2023
Director
Buy indirect
400
$7.25
$2.90K
SEIDENBERG BETH C
8 Feb 2023
Director
Buy indirect
45,357
$7.22
$327.48K
SEIDENBERG BETH C
7 Feb 2023
Director
Buy indirect
87,956
$7.08
$622.73K
Sofinnova Venture Partners X, L.P.
6 Feb 2023
10% owner
Buy
285,714
$7.00
$2.00M
ENRIGHT PATRICK G
6 Feb 2023
Director
Buy indirect
1,714,285
$7.00
$12.00M
Longitude Capital Partners IV, LLC
6 Feb 2023
10% owner
Buy indirect
1,714,285
$7.00
$12.00M
SEIDENBERG BETH C
6 Feb 2023
Director
Buy indirect
131,602
$7.03
$925.16K
SEIDENBERG BETH C
3 Feb 2023
Director
Buy indirect
46,163
$7.24
$334.22K
Grant Sean
15 Jun 2022
Chief Financial Officer
Buy indirect
992
$13.60
$13.49K
Grant Sean
15 Jun 2022
Chief Financial Officer
Buy indirect
857
$13.60
$11.66K
Grant Sean
15 Jun 2022
Chief Financial Officer
Buy indirect
335
$13.60
$4.56K
Grant Sean
15 Jun 2022
Chief Financial Officer
Buy indirect
2,816
$13.60
$38.30K
Sofinnova Venture Partners X, L.P.
10 Feb 2022
10% owner
Buy
266,666
$15.00
$4.00M
ENRIGHT PATRICK G
10 Feb 2022
Director
Buy indirect
333,333
$15.00
$5.00M
Longitude Capital Partners IV, LLC
10 Feb 2022
10% owner
Buy indirect
333,333
$15.00
$5.00M
Grant Sean
6 Feb 2022
Chief Financial Officer
Buy
14,285
$7.00
$100.00K
Young Joseph R
6 Feb 2022
SVP, Finance, Chief Acct Offcr
Buy
5,714
$7.00
$40.00K
Abingworth LLP
18 May 2021
10% owner
Buy indirect
772,727
$11.00
$8.50M
EMSTER KURT VON
18 May 2021
Director
Buy indirect
772,727
$11.00
$8.50M
ENRIGHT PATRICK G
18 May 2021
Director
Buy indirect
909,090
$11.00
$10.00M
Katabi Maha
18 May 2021
Director
Buy indirect
727,272
$11.00
$8.00M
Longitude Capital Partners IV, LLC
18 May 2021
10% owner
Buy indirect
909,090
$11.00
$10.00M
Sofinnova Venture Partners X, L.P.
18 May 2021
10% owner
Buy
727,272
$11.00
$8.00M
EMSTER KURT VON
17 May 2021
Director
Buy
17,828
$12.04
$214.66K
Show all 238 transactions →

What was left out

Form 4 filings counted 192
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 138
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 16,107,626
Sales filed before the plan box existed 5
History held since 17 May 2021